Improvements in medical therapy, carotid-artery stenting, and carotid endarterectomy call into question the preferred ...

Protecting health is a team sport — yet the public health and clinical care systems meant to advance this goal have been siloed for too long.

A 26-year-old woman was referred to the pulmonary hypertension clinic with a 6-month history of exertional dyspnea and hoarseness. Vocal-fold paralysis was seen on laryngoscopy (shown in a video).

Explore the current issue of The New England Journal of Medicine (Vol. 393 No. 20).

The Nova food-classification system has advanced efforts to address modern diets of highly processed foods. But it’s unclear whether it can be codified at a national level to support public health.

In this international, randomized trial, we assigned critically ill adults who were undergoing invasive ventilation to receive intravenous pantoprazole (at a dose of 40 mg daily) or matching placebo.

Collaborators from Massachusetts General Hospital, Community Servings, and the University of North Carolina provide medically tailored meals for people with chronic illness and food insecurity.

Competition is vital to the success of Medicare Advantage but is limited. As the program grows rapidly under favorable payment policy, a reformed traditional Medicare could provide valuable competi ...

Personalized therapies hold tremendous promise but challenge traditional models of drug and biologic development. The FDA outlines a path to market entry for products where a randomized trial is no ...

The Affordable Care Act (ACA) was signed into law 10 years ago. This first of two Health Policy Reports reviewing the challenges and successes of the law focuses on the provisions of the law that ...

No medications are currently approved for the treatment of nonmonogenic, nonsyndromic obesity in children younger than 12 years of age. Although the use of liraglutide has been shown to induce weight ...

To the Editor: The results of the C-POST trial, reported by Rischin and colleagues (August 21/28 issue), 1 highlight improvements in disease-free survival with adjuvant cemiplimab. As the authors ...